Malaysia’s medical tourism earned more than RM3 billion in hospital revenue last year and, on an estimated fourfold multiplier, fed RM10 billion to RM12 billion into the wider economy, Free Malaysia Today reported. Hospital receipts have climbed steadily, from RM2.25 billion in 2023 to RM2.72 billion in 2024 and past RM3 billion last year, the paper said. The bigger figure rests on that multiplier, put at four times the direct hospital sum, and it is the part worth reading with care. The RM3 billion is money banked. The RM10 billion to RM12 billion is an estimate of everything the trade is assumed to touch around it.
Where the money lands
The spending that medical tourism carries reaches well beyond hospitals, the paper said, into shopping, hotels, food and transport. Mint Leong of the Malaysia Inbound Tourism Association said medical tourists “spend more and stay longer than regular leisure tourists,” rarely travel alone, and combine treatment with sightseeing and shopping. Tourism data cited by the paper put shopping as the largest single share of visitor spending, ahead of accommodation and food. That profile is why the trade counts for more than its hospital bills, because a foreign patient who books a fortnight of recovery spends across a chain of businesses that never sends an invoice to a hospital.
The spending also spreads across the country rather than pooling in the capital. In 2024 the central region recorded about RM1.14 billion in medical receipts, roughly 42 per cent of the national total, Free Malaysia Today reported, with the northern region close behind on 40 per cent and the south on 12 per cent. The East Coast states, Sabah and Sarawak took the rest. A trade concentrated in one city would be easy to dismiss; one that lands across several regions is what lets the paper call medical tourism a pillar rather than a niche.
Steadier money than most tourism
Medical tourism also steadied Malaysia’s wider tourism recovery after the pandemic. Leong said the trade had recovered in parallel with leisure travel once borders reopened in April 2022, when pent-up demand for delayed treatment lifted receipts faster than expected. Foreign patients tend to spend more than leisure visitors and to travel outside the holiday peaks, the paper said, which makes their receipts less seasonal and steadier through a downturn. That steadiness is the quiet case for the trade, because a hospital booking is planned months ahead and rarely cancelled when a currency wobbles.
The specialist question
That revenue reopens an argument that follows medical tourism wherever it grows. Dr Thirunavukarasu Rajoo, president of the Malaysian Medical Association, said the trade “can help retain specialists in Malaysia by offering professional opportunities and competitive income,” but he warned that unchecked private growth could pull doctors from public hospitals where the need is greatest. That tension is the standing risk under the revenue, because the same money that keeps specialists in Malaysia can also draw them from the wards that treat citizens. The specialist-drain debate has run alongside every revenue record Malaysia has reported. Foreign patients still make up a small share of private-hospital discharges, the paper said, which suggests the trade is complementing domestic demand rather than displacing it, for now.
What operators should watch
In 2024 medical tourism was 0.14 per cent of Malaysia’s RM1.9 trillion gross domestic product, and the Malaysia Healthcare Travel Council wants RM7 billion in revenue by 2030, a target that would lift the share to 0.26 per cent. A target is an announcement, not a receipt. The figures to watch are whether hospital revenue clears the RM7 billion mark by 2030, whether the fourfold multiplier holds up as the trade grows, and whether public hospitals keep their specialists as private hospitals and hotels expand around them. A multiplier is a model; the payroll of a public hospital is a fact.
